More than 75% of hospitals and imaging centers that perform mammography in the U.S. have resumed breast cancer screening operations, according to data from breast imaging software developer Volpara Solutions.
Statistical data from the company's VolparaEnterprise software shows that exam volumes are also recovering rapidly, according to the vendor. As restrictions on nonemergency healthcare services are easing, imaging facilities are expanding their hours and offering weekend appointments to manage the backlog of patients who weren't able to attend their regularly scheduled screening dates due to the COVID-19 pandemic, Volpara said.
At many sites, exam volumes have returned to within 10% of prepandemic levels, and about 5% of facilities are recording exam volumes higher than previous levels, the company said.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
